Enterprise League logo
Precision BioSciences, Inc. Logo

Precision BioSciences, Inc.

Durham, United States (US) · Health and Medical

Do you work at Precision BioSciences, Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

#gene editing

#gene therapy

Precision BioSciences, Inc. is a Health and Medical company based in Durham, United States (US), founded in 2006, with 50-100 employees. Precision BioSciences, Inc.'s profile is verified on Enterprise League.

Overview

Precision BioSciences is a Durham, North Carolina-based gene editing company pioneering innovative solutions for treating genetic diseases.

We are dedicated to improving lives through our proprietary ARCUS genome editing platform, a revolutionary technology that allows for precise DNA modification – including gene knockouts, gene insertions, and gene repairs – within living cells.

ARCUS represents a significant advancement in gene therapy, offering the potential to cure previously untreatable conditions like chronic Hepatitis B and Duchenne Muscular Dystrophy.

Precision BioSciences is focused on advancing our clinical programs, PBGENE-HBV and PBGENE-DMD, with the goal of bringing transformative medicines to patients in need. We are a public company (Nasdaq: DTIL) committed to scientific excellence and patient well-being.
Visit Official Website

Most teams do this before shortlisting


Contact Details

+1919.314.5512
info@precisionbiosciences.com

Durham, United States (US), 302 East Pettigrew Street

Founded

2006

Company Type

Public Limited Company

Employees

50-100

Categories

Biopharma
Life Science
Biotechnology

Keywords

#gene editing

#gene therapy

Awards

• 2026 OpenSee all

Products

Default Product Image
PBGENE-HBV
Biotechnology

A first-in-class gene editing therapy for chronic Hepatitis B, utilizing the ARCUS platform to eliminate cccDNA and inactivate integrated HBV DNA.

N/A


Services

Default Product Image
ARCUS Genome Editing Platform
Biotechnology

Precision BioSciences’ proprietary ARCUS genome editing platform enables precise and versatile DNA modification within living cells. It utilizes sequence-specific nucleases to achieve gene knockouts, insertions, and repairs, offering a novel approach to gene therapy.

N/A

Companies teams usually look at after Precision BioSciences, Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.